Transition to Ambulatory Bariatric Surgery (TABS) Trial
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Jun 5, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Transition to Ambulatory Bariatric Surgery (TABS) Trial is a study looking at two different options for patients after they have bariatric surgery, which is a procedure to help with weight loss. The trial will compare patients who go home on the same day of their surgery with those who stay in the hospital for at least one night. The main goal is to see if there are differences in how often patients need to visit the emergency room within a week after their surgery.
To be eligible for this study, participants should have a body mass index (BMI) of 60 or less and be scheduled for either a sleeve gastrectomy or gastric bypass surgery at the hospital involved in the trial. However, certain medical conditions, like uncontrolled diabetes or heart problems, may prevent someone from joining. If you participate, you will be randomly assigned to one of the two groups, and you can expect careful follow-up to monitor your recovery. This trial is not yet recruiting participants, but it aims to provide valuable information about the best ways to handle recovery after bariatric surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI ≤ 60 kg/m2
- • Primary Sleeve gastrectomy or Gastric Bypass,
- • Undergoing bariatric surgery at sponsor site
- Exclusion Criteria:
- • Type 1 Diabetes
- • Myocardial Infarction
- • Unstable Angina or Heart Failure
- • Prior Stroke
- • Solid organ transplantation
- • Systemic glucocorticoid prior 28 days
- • Severe Obstructive Sleep Apnea
- • Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90)
- • Untreated Hyperthyroidism
- • Chronic Kidney Disease (EGFR \< 60)
- • Current anticoagulant use,
- • Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%)
- • Chronic opioid use
- • Insulin dependence.
- • Need for extended venous thromboembolic event prophylaxis,
- • \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
- • Patient lives \> 130 miles from the hospital.
- • Tobacco use in last 12 months
- • Desire to become pregnant or active pregnancy
- • Prisoners
- • Unable or unwilling to follow-up
- • Unable to understand or provide consent
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported